SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 71.77 |
| Enterprise Value ($M) | 55.48 |
| Book Value ($M) | 252.95 |
| Book Value / Share | 2.72 |
| Price / Book | 0.28 |
| NCAV ($M) | 159.01 |
| NCAV / Share | 1.71 |
| Price / NCAV | 0.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.16 |
| Current Ratio | 7.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 219.38 |
| Assets | 313.31 |
| Liabilities | 60.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.99 |
| Operating Income | -162.12 |
| Net Income | -149.10 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -138.20 |
| Cash from Investing | 86.61 |
| Cash from Financing | 16.72 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Haurwitz Rachel E. | 5.00 | 7.70 | |
| 13G/A | BlackRock, Inc. | 6.80 | -11.13 | |
| 13G/A | Bank Of America Corp /de/ | 2.20 | -61.35 | |
| 13G/A | PFM Health Sciences, LP | 4.80 | ||
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 3.00 | -38.88 | |
| 13G/A | Vanguard Group Inc | 5.11 | 0.00 | |
| 13G/A | State Street Corp | 1.80 | -68.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 274,561 | 992,284 | 27.67 | |
| 2,331,906 | 3,807,498 | 61.25 | |
| 526,425 | 1,378,780 | 38.18 | |
| 151,807 | 566,195 | 26.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COGT – Cogent Biosciences, Inc. | COLL – Collegium Pharmaceutical, Inc. |
| CPIX – Cumberland Pharmaceuticals Inc. | CRGX – CARGO Therapeutics, Inc. |
| CRNX – Crinetics Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io